Citadel Advisors’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRA
NA
HCM
HI
Citadel Advisors's BMRA Position: Q2 2024 in Review
Citadel Advisors sold out of Biomerica (BMRA) in Q2 2024, closing a stake of 4,423 shares — an estimated $29.4K sold.
Citadel Advisors first reported a position in BMRA in Q1 2019 and held it in 9 quarters. The position peaked at $155K in Q4 2022. 35 funds tracked by Wall St. Rank hold BMRA as of Q2 2024.
- Citadel Advisors reported no remaining Biomerica position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 4,423 Biomerica shares in Q2 2024, an estimated $29.4K.
- Citadel Advisors first reported a position in Biomerica in Q1 2019 and held it in 9 quarters.
- Citadel Advisors's Biomerica position peaked at $155K in Q4 2022.
- 35 funds tracked by Wall St. Rank held Biomerica as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.